1. Home
  2. SBRA vs ASH Comparison

SBRA vs ASH Comparison

Compare SBRA & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SBRA
  • ASH
  • Stock Information
  • Founded
  • SBRA 2010
  • ASH 1924
  • Country
  • SBRA United States
  • ASH United States
  • Employees
  • SBRA N/A
  • ASH N/A
  • Industry
  • SBRA Real Estate Investment Trusts
  • ASH Specialty Chemicals
  • Sector
  • SBRA Real Estate
  • ASH Consumer Discretionary
  • Exchange
  • SBRA Nasdaq
  • ASH Nasdaq
  • Market Cap
  • SBRA N/A
  • ASH 2.4B
  • IPO Year
  • SBRA N/A
  • ASH N/A
  • Fundamental
  • Price
  • SBRA $18.31
  • ASH $52.51
  • Analyst Decision
  • SBRA Buy
  • ASH Buy
  • Analyst Count
  • SBRA 7
  • ASH 5
  • Target Price
  • SBRA $19.71
  • ASH $70.75
  • AVG Volume (30 Days)
  • SBRA 2.7M
  • ASH 577.2K
  • Earning Date
  • SBRA 08-06-2025
  • ASH 08-05-2025
  • Dividend Yield
  • SBRA 6.55%
  • ASH 3.15%
  • EPS Growth
  • SBRA 185.79
  • ASH N/A
  • EPS
  • SBRA 0.60
  • ASH N/A
  • Revenue
  • SBRA $720,247,000.00
  • ASH $1,949,000,000.00
  • Revenue This Year
  • SBRA $5.91
  • ASH N/A
  • Revenue Next Year
  • SBRA $5.30
  • ASH $2.35
  • P/E Ratio
  • SBRA $30.58
  • ASH N/A
  • Revenue Growth
  • SBRA 10.76
  • ASH N/A
  • 52 Week Low
  • SBRA $15.11
  • ASH $45.21
  • 52 Week High
  • SBRA $20.03
  • ASH $98.44
  • Technical
  • Relative Strength Index (RSI)
  • SBRA 57.85
  • ASH 57.48
  • Support Level
  • SBRA $18.10
  • ASH $49.82
  • Resistance Level
  • SBRA $18.70
  • ASH $51.88
  • Average True Range (ATR)
  • SBRA 0.38
  • ASH 1.38
  • MACD
  • SBRA 0.01
  • ASH 0.22
  • Stochastic Oscillator
  • SBRA 71.43
  • ASH 76.78

About ASH Ashland Inc.

Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.

Share on Social Networks: